Tag: drug_safety_labeling

FDA Requires New Label Warnings on GLP-1 Drugs Over Rare Eye Condition Risk

9 Nov 2026 1:17 p.m. · Source: US Food and Drug Administration

The FDA is requiring makers of GLP-1 receptor agonist medications to add warnings about a potential increased risk of NAION, a rare eye condition that can cause permanent vision loss.

Health Politics and Government Federal Government Medical Science Law Enforcement US Food and Drug Administration GLP-1 receptor agonists NAION Drug safety labeling Vision loss MedWatch Type 2 diabetes Food Recalls FDA Drugs